Nancy Lurker, Director at EyePoint Pharmaceuticals, Inc. (EYPT), bought 3,173 shares at $7.88 ($25K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
Open-market purchase of $25k EYPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| EYPT | SELL | 2025-12-01 | $10K | — | Filing → |
| EYPT | SELL | 2024-01-25 | $1.7M | — | Filing → |
| EYPT | SELL | 2023-12-06 | $830K | — | Filing → |